Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergy.

JCI insight·2026
Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026
Same author

Nanoparticle modulation of immune and vascular microenvironment dynamics following spinal cord injury.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Nanoparticle induction of antigen-presenting monocyte-derived dendritic cells relieves immunosuppression and inhibits metastasis.

Cell biomaterials·2026
Same author

Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease.

Brain : a journal of neurology·2026
Same author

Combating respiratory diseases with mucosal vaccines.

Journal of virology·2026
Same journal

IL-33 scripts cancer immunity.

Trends in immunology·2026
Same journal

Mitochondrial Ca<sup>2+</sup> signaling: A metabolic rheostat defining tumor and immune cell fate.

Trends in immunology·2026
Same journal

Cross-priming underlies the efficacy of antibody-drug conjugates and immunotherapy combinations.

Trends in immunology·2026
Same journal

Gut microbiome metabolites meet immunometabolism in inflammatory bowel disease.

Trends in immunology·2026
Same journal

Metabolic regulatory nodes of the inflammasome and inflammatory cell death.

Trends in immunology·2026
Same journal

Parental leave in immunology - 6.

Trends in immunology·2026
See all related articles

Related Experiment Video

Updated: Apr 9, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Harnessing nanoparticles for immune modulation.

Daniel R Getts1, Lonnie D Shea2, Stephen D Miller3

  • 1The Discipline of Pathology, School of Medical Sciences, Bosch Institute, Sydney Medical School, The University of Sydney, Sydney, NSW 2006, Australia; Department of Microbiology-Immunology and Interdepartmental Immunobiology Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Cour Pharmaceutical Development Company, Elmhurst, IL, USA.

Trends in Immunology
|June 20, 2015
PubMed
Summary
This summary is machine-generated.

Nanoparticle therapies engineered for immune regulation show promise for treating autoimmune diseases. These advanced materials control inflammation and restore immune tolerance by interacting with the mononuclear phagocyte system.

More Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.1K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.7K

Related Experiment Videos

Last Updated: Apr 9, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

13.1K
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.7K

Area of Science:

  • Immunology
  • Nanotechnology
  • Materials Science

Background:

  • Nanoparticle therapies for immune regulation are rapidly advancing.
  • Innovations in nanotechnology and understanding immune-mediated diseases drive this growth.
  • Nanoparticles interact with the mononuclear phagocyte system, impacting immune function.

Purpose of the Study:

  • To review recent advances in nanoparticle-based immune-modulation therapies.
  • To discuss polymeric nanoparticle development, including modification and delivery.
  • To explore factors critical for the clinical deployment of these therapies.

Main Methods:

  • Review of recent scientific literature on nanoparticle-based immune modulation.
  • Analysis of nanoparticle interactions with the mononuclear phagocyte system.
  • Discussion of polymeric nanoparticle design and delivery strategies.

Main Results:

  • Nanoparticle engineering offers promising preclinical results for immune regulation.
  • Understanding nanoparticle-IPS interactions highlights potential for controlling inflammation.
  • Restoring peripheral immune tolerance in autoimmune disease is a key therapeutic goal.

Conclusions:

  • Nanoparticle-based therapies hold significant potential for managing autoimmune diseases.
  • Strategic nanoparticle design, delivery, and understanding immune interactions are crucial.
  • Further research into clinical deployment factors is necessary for therapeutic success.